PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportsspinal cord injuries
MeSH D013119 - spinal cord injuries
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D014947:Wounds and injuries
$
Success rate
D020196:Nervous system trauma
0 Companies
0 Drugs
Success rate
D013118:Spinal cord diseases
0 Companies
0 Drugs
Success rate
D013119: 
Spinal cord injuries
$
Success rate
D013117:Spinal cord compression
0 Companies
0 Drugs
Success rate
D020210:Central cord syndrome
0 Companies
0 Drugs
Success rate
D020211:Autonomic dysreflexia
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaBaclofen Baclofen  1988-07-21   
Pregabalin Pregabalin  2019-07-19   
MylanBaclofen Baclofen  2005-07-29   
Pregabalin Pregabalin  2019-09-20   
Pregabalin Pregabalin Mylan  2015-06-24   
Pregabalin Pregabalin Mylan Pharma  2015-06-25   
CiplaPregabalin Pregabalin  2019-07-19   
Lupin ResearchPregabalin Pregabalin  2022-05-03   
SandozPregabalin Pregabalin Sandoz  2015-06-19   
Pregabalin Pregabalin Sandoz GmbH  2015-06-19   
NovartisBaclofen Lioresal  1982-01-01   
UCBBaclofen Kemstro  2003-10-30   
Aurobindo PharmaBaclofen Baclofen  2021-07-13   
Pregabalin Pregabalin  2023-03-29   
Dr Reddys LaboratoriesPregabalin Pregabalin  2019-07-19   
Rising PharmaceuticalsPregabalin Pregabalin  2019-07-19   
Baclofen Baclofen  2021-03-05   
1
2
3
4
5
6
>
Clinical Trials
Historical Success Rate
Phase 1
63%
22/35
Phase 2
49%
31/63
Phase 3
22%
8/36
Approved: 3Overall Success rate: 7%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Mylan
UCB
1
2
3
4
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use